Oliver T, Lawson A, Lee-Six H, Tollit A, Jung H, Hooks Y
Nat Genet. 2025; 57(3):515-521.
PMID: 40000831
PMC: 11906363.
DOI: 10.1038/s41588-025-02097-2.
Bentham R, Jones T, Black J, Martinez-Ruiz C, Dietzen M, Litovchenko M
Nat Genet. 2025; 57(3):694-705.
PMID: 39966644
PMC: 11906351.
DOI: 10.1038/s41588-025-02086-5.
Zhang D, Zhang A, He X, Deng S
Adv Biotechnol (Singap). 2025; 2(2):18.
PMID: 39883325
PMC: 11740857.
DOI: 10.1007/s44307-024-00025-9.
Poon G, Vedi A, Sanders M, Laurenti E, Valk P, Blundell J
Cell Genom. 2025; 5(2):100744.
PMID: 39842433
PMC: 11872528.
DOI: 10.1016/j.xgen.2024.100744.
Wang N, Pachai M, Li D, Lee C, Warda S, Khudoynazarova M
Nat Genet. 2025; 57(1):165-179.
PMID: 39806204
PMC: 11735410.
DOI: 10.1038/s41588-024-02015-y.
A novel mouse model of upper tract urothelial carcinoma highlights the impact of dietary intervention on gut microbiota and carcinogenesis prevention despite carcinogen exposure.
Yamamoto A, Kawashima A, Uemura T, Nakano K, Matsushita M, Ishizuya Y
Int J Cancer. 2024; 156(7):1439-1456.
PMID: 39693209
PMC: 11789449.
DOI: 10.1002/ijc.35295.
Emerging strategies to investigate the biology of early cancer.
Zhou R, Tang X, Wang Y
Nat Rev Cancer. 2024; 24(12):850-866.
PMID: 39433978
DOI: 10.1038/s41568-024-00754-y.
The interplay of mutagenesis and ecDNA shapes urothelial cancer evolution.
Nguyen D, Hooper W, Liu W, Chu T, Geiger H, Shelton J
Nature. 2024; 635(8037):219-228.
PMID: 39385020
PMC: 11541202.
DOI: 10.1038/s41586-024-07955-3.
Steering research on mRNA splicing in cancer towards clinical translation.
Anczukow O, Allain F, Angarola B, Black D, Brooks A, Cheng C
Nat Rev Cancer. 2024; 24(12):887-905.
PMID: 39384951
PMC: 11698124.
DOI: 10.1038/s41568-024-00750-2.
Cancer risk assessment of premalignant breast tissues from patients with BRCA mutations by genome profiling.
Hirose T, Ikegami M, Kida K, Ueno T, Kitada R, Wang L
NPJ Breast Cancer. 2024; 10(1):87.
PMID: 39366967
PMC: 11452615.
DOI: 10.1038/s41523-024-00693-9.
Clonal dynamics and somatic evolution of haematopoiesis in mouse.
Kapadia C, Williams N, Dawson K, Watson C, Yousefzadeh M, Le D
bioRxiv. 2024; .
PMID: 39345649
PMC: 11429886.
DOI: 10.1101/2024.09.17.613129.
Unveiling correlations between aristolochic acids and liver cancer: spatiotemporal heterogeneity phenomenon.
Li C, Li X, Niu M, Xiao D, Luo Y, Wang Y
Chin Med. 2024; 19(1):132.
PMID: 39342223
PMC: 11439320.
DOI: 10.1186/s13020-024-01003-y.
Self-sustaining long-term 3D epithelioid cultures reveal drivers of clonal expansion in esophageal epithelium.
Herms A, Fernandez-Antoran D, Alcolea M, Kalogeropoulou A, Banerjee U, Piedrafita G
Nat Genet. 2024; 56(10):2158-2173.
PMID: 39313617
PMC: 11525200.
DOI: 10.1038/s41588-024-01875-8.
Mutational Landscapes of Normal Skin and Their Potential Implications in the Development of Skin Cancer: A Comprehensive Narrative Review.
Riew T, Kim Y
J Clin Med. 2024; 13(16).
PMID: 39200957
PMC: 11355262.
DOI: 10.3390/jcm13164815.
Comparative analysis of non-coding and coding DNA mutations in flat urothelial lesions: biological implications and insights.
Musangile F, Matsuzaki I, Iwamoto R, Sagan K, Nishikawa M, Mikasa Y
Virchows Arch. 2024; .
PMID: 39167111
DOI: 10.1007/s00428-024-03901-w.
Imposter among us: field cancerization in the bladder.
Rodden D, Chung E, Pittie R, Miyamoto D
Transl Androl Urol. 2024; 13(7):1319-1323.
PMID: 39100848
PMC: 11291423.
DOI: 10.21037/tau-24-8.
Molecular biomarkers of progression in non-muscle-invasive bladder cancer - beyond conventional risk stratification.
Olislagers M, de Jong F, Rutten V, Boormans J, Mahmoudi T, Zuiverloon T
Nat Rev Urol. 2024; 22(2):75-91.
PMID: 39095581
DOI: 10.1038/s41585-024-00914-7.
Sensitivity and Specificity in Urine Bladder Cancer Markers - Is it that Simple?.
Roghmann F, Goebell P, Dyrskjot L, van Rhijn B, Kafferlein H, Hakenberg O
Bladder Cancer. 2024; 8(1):1-4.
PMID: 38994515
PMC: 11181706.
DOI: 10.3233/BLC-211602.
CRISPR-Cas9 for selective targeting of somatic mutations in pancreatic cancers.
Teh S, Bowland K, Halper-Stromberg E, Kotwal A, Bennett A, Skaist A
NAR Cancer. 2024; 6(2):zcae028.
PMID: 38915758
PMC: 11195629.
DOI: 10.1093/narcan/zcae028.
Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets.
Zhang S, Xiao X, Yi Y, Wang X, Zhu L, Shen Y
Signal Transduct Target Ther. 2024; 9(1):149.
PMID: 38890350
PMC: 11189549.
DOI: 10.1038/s41392-024-01848-7.